CD19 and cancer: Since CIKZ cells can be more extensively expanded than γδ T cells alone while still exhibiting a relatively high cytolytic activity, we proceeded to test whether anti-CD19 CAR-redirected CIKZ cells display improved cytotoxicity against CD19-positive cancer cells.